ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,864.67
0.40%
US Tech 100
19,783.20
0.68%
Dow Jones
43,275.91
0.09%
Brent Oil
72.935
0.00%
Bitcoin
68,244.92
-0.26%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
10/19/20248:14AMGlobeNewswire Inc.KFSHRC Pioneers Cancer Treatment with Breakthrough Therapies and Exceptional Outcomes
10/19/20248:09AMPR Newswire (Canada)Pluribus Technologies Corp. Announces Further Amendment to Second Forbearance AgreementTSXV:PLRBPluribus Technologies Corp
10/19/20248:00AMGlobeNewswire Inc.Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s MacroglobulinemiaNASDAQ:NRIXNurix Therapeutics Inc
10/19/20248:00AMPR Newswire (Canada)Investors in Common Stock and Certain Debt Securities Offered by Valeant Pharmaceuticals International, Inc. May be Entitled to Payment from an SEC Fair Fund
10/19/20248:00AMPR Newswire (US)Kaia Health Appoints Adam Pellegrini as Global CEO And Launches The First Digital Pulmonary Rehab Program In Partnership With The COPD Foundation
10/19/20248:00AMPR Newswire (Canada)Les investisseurs dans des actions ordinaires et certains titres de créance proposés par Valeant Pharmaceuticals International, Inc. pourraient avoir droit à un paiement dérivé d'un Fair Fund de la SEC
10/19/20248:00AMPR Newswire (US)Investors in Common Stock and Certain Debt Securities Offered by Valeant Pharmaceuticals International, Inc. May be Entitled to Payment from an SEC Fair Fund
10/19/20247:21AMAlliance NewsAlliance NewsUK PM vows to keep manifesto promises amid tax threshold freeze report
10/19/20247:02AMPR Newswire (US)GITEX GLOBAL concludes, reinforcing its status as the world's largest and most dominant technology event
10/19/20247:00AMPR Newswire (Canada)L'opposition libérale réclame un Directeur parlementaire du budget de toute urgence
10/19/20246:59AMPR Newswire (US)GITEX GLOBAL concludes, reinforcing its status as the world's largest and most dominant technology event
10/19/20246:33AMPR Newswire (Canada)/R E P R I S E -- Les syndicats qui représentent les employé(e)s de la Ville de Laval dénoncent le manque de collaboration du Maire Boyer/
10/19/20246:20AMAlliance NewsAlliance NewsGermany's Scholz expected in Istanbul for talks with Erdogan
10/19/20246:19AMAlliance NewsAlliance NewsTrump says US President Biden tries to "hold back" Netanyahu
10/19/20246:14AMAlliance NewsAlliance NewsHarris eyes Trump's age in US White House race amid exhaustion report
10/19/20246:13AMAlliance NewsAlliance NewsUK needs China diplomacy but security comes first – foreign secretary
10/19/20246:12AMAlliance NewsAlliance NewsChina's Xi calls for troops to boost war preparedness
10/19/20245:39AMPR Newswire (US)GITEX GLOBAL 2024 sets the blueprint for the future of mobility, showcasing AI and autonomous solutions
10/19/20245:37AMPR Newswire (US)GITEX GLOBAL 2024 sets the blueprint for the future of mobility, showcasing AI and autonomous solutions
10/19/20245:29AMPR Newswire (US)Green, Low-Carbon, and Full-fledged Smart Mobility Products Gain Attention at the 136th Canton Fair
10/19/20243:00AMPR Newswire (US)My China Story: The "Pearl of Western Jiangxi" attracted foreign journalists and bloggers from seven countries
10/19/20242:05AMPR Newswire (US)Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women's Maternal Mental Healthcare with its MamaLift and MamaLift Plus Solutions
10/19/20242:05AMPR Newswire (US)Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women's Maternal Mental Healthcare with its MamaLift and MamaLift Plus Solutions
10/19/20241:00AMPR Newswire (US)Accord Healthcare receives positive CHMP opinion for IMULDOSA®, a ustekinumab biosimilar to Stelara®
10/19/20241:00AMPR Newswire (US)Salvi, Schostok & Pritchard trial team recognized with Trial Lawyer Excellence Award for $75.8M verdict
10/18/202411:44PMGlobeNewswire Inc.XYZ Media’s ‘Next Generation of Innovators' Highlights James Gu’s Research: Advancing Personalized Cancer Treatment with Digital Twin Technology
10/18/202411:25PMBusiness WireMichael D. Ratner, Founder and CEO of OBB Media, Named Among the Top 100 Most Exceptional Entrepreneurs for Second Consecutive Year
10/18/202411:00PMGlobeNewswire Inc.NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)AMEX:CLDICalidi Biotherapeutics Inc
10/18/202410:51PMPR Newswire (Canada)Huawei présente un article important intitulé « The Digital Dividend - ICT Maturity Fuels Economic Growth » lors du salon GITEX GLOBAL 2024
10/18/202410:46PMGlobeNewswire Inc.Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming DaysNASDAQ:TVGNTevogen Bio Holdings Inc

Your Recent History

BIT
FK2V2L
Vontobel
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved